I am happy to share with you that Prof. Franz Fazekas’s health has greatly improved.  We are in regular contact with him and his wife and expect (and wish) further recovery. Unfortunately, his current condition does not allow him to resume his function as President of our Society. As a consequence, the board has decided to ask me to take over his duties from September 1, 2019. To support the board and in accord with our bylaws, Prof. D. Vodusek, who already served in the EAN board, was appointed as member at large (until the next elections in Paris). I am very thankful to the entire board, the office, and particularly to Prof. G. Deuschl for their trust, support and advice in this delicate transition period.

This month’s selected paper is a working group report that addresses a recently described disorder, limbic-predominant age-related TDP-43 encephalopathy (LATE), which is emerging as an important cause of cognitive impairment in the elderly. The group make recommendations for standardised neuropathological evaluation and identify research avenues to better understand this evolving new disease phenotype.

Sweden, population 10 million, is the largest of the Nordic countries. The population is concentrated to the southern large-city areas, including the capital Stockholm (population 2 million) and the cities of Gothenburg and Malmö. Geographically, Sweden is the third largest country in the EU. The northern parts of the country extend above the artic circle, but the climate is relatively mild (average temperature about 0°C in January and 21°C in July) on account of the Gulf Stream carrying warmer Caribbean water to the region.!

Second dose of intravenous immunoglobulin for Guillain-Barre syndrome

Antiparanodal antibodies in CIDP.

Role of right frontal regions in cognition: evidence from intraoperative stimulation in awake people

Fluoroquinolone Use Linked to Higher Risk of Peripheral Neuropathy

EXTEND study: More evidence on thrombolysis beyond traditional time windows

A consensus review on the development of palliative care for patients with chronic and progressive neurological disease.

Under the umbrella of the Women’s Brain Project (WBP), the second international Forum on Women’s Brain and Mental Health was held in Zurich (Switzerland) on June 8-9, 2019.

The Scientific Committee is fully committed to a great mission: To increase and share the best clinical knowledge and the cutting-edge information from translational research in all neurological fields. Main actions are i) to facilitate exchanges and synergies with the Scientific Panels ii) to support the Guideline Production Group (update and diffusion of expertise and best clinical practice), iii) to interact positively with other scientific societies with reciprocal exchanges and liaise with the European Affairs sub-Committee to increase the awareness of Neurology in Europe.

The EAN-Day in Estonia was organised in the 31st of May, 2019, in the Laulasmaa Conference Centre near Tallinn, next to the Annual Congress of the Estonian Ludvig Puusepp Society of Neurologists and Neurosurgeons. Three speakers from different European countries were invited, supported by the EAN , to lecture in topics by local needs: Professor Jean-Marc Leger an expert on peripheral neuropathies, from the University Hospital Pitié-Salpêtrière, Paris, France; Professor Nils Erik Gilhus from the Haukeland University Hospital, Bergen, Norway, whose field in myasthenia; and Professor Alessandro Padovani from Brescia, Italy, to lecture on different aspects of dementias.

To celebrate World Brain Day (July 22nd), the European Federation of Neurological Associations [EFNA] co-hosted events in four European capitals – Brussels, Bucharest, Dublin and Warsaw!

During 2018 EFNA continued to build on some of their ongoing projects – such as the MEP Interest Group on Brain, Mind and Pain and the Training Initiatives for Neurology Advocates.